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A 24-year-old male, known case of rheumatic
heart disease, who had undergone mechanical
mitral valve replacement 4years ago, was
referred to our echocardiography laboratory,
due to fever, chills, and severe anorexia,
3weeks after being discharged due to COVID-
19 infection. He had been diagnosed due to a
chest X-ray suggestive of viral pneumonia
(Panel A) and a positive RT–PCR for SARS-
COV-2. On admission, he was febrile (38C),
had tachycardia (heart rate: 100/min), and a
normal oxygen saturation in room air and his
electrocardiogram displayed sinus tachycardia
(Panel B). Due to a high suspicion of infectious
endocarditis (IE) on echocardiographic exami-
nation, a transoesophageal echocardiogram
was performed, which revealed several typical
vegetations on the posterior prosthetic mitral
valve leaflet (Panel C). His previous echocardio-
gram had demonstrated normal functioning
mitral valve prosthesis and a left ventricular
ejection fraction of 45%. Blood culture results
came back positive for Staphylococcus aureus.
Other noticeable laboratory tests included leu-
cocytosis and an elevated C-reactive protein
(72mg/L, normal level<3).
Patient was treated with Azithromycin, Hydroxychloroquine, and corticosteroids and was discharged 2 weeks later. After 6 weeks of
antibiotic treatment, repeated trans-thoracic oesophageal echocardiogram (TEE) displayed healing of the vegetative lesions (Panel D).
Up till now, there has been limited evidence on COVID-19 and IE, but since the process of vegetation development begins through tran-
sient bacteraemia, followed by binding of bacteria to damaged endothelium, Coronavirus infection and the systemic inflammation caused by
it can be a potential risk factor for IE, particularly in susceptible patients with underlying diseases. Furthermore, the administration of corti-
costeroids and its role in precipitating the condition is unknown.
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